The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost

A salama, Nicole de Rosa, Randall Scheri, James Herndon, D Tyler, Jennifer Marcello, Scott Pruitt, Amy Abernethy

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

    Original languageEnglish
    Pages (from-to)637-641
    Number of pages5
    JournalCancer Investigation
    Volume30
    Issue number9
    DOIs
    Publication statusPublished - Nov 2012

    Keywords

    • Life expectancy
    • Melanoma
    • Mortality
    • Potential years of life lost
    • Survival

    Fingerprint Dive into the research topics of 'The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost'. Together they form a unique fingerprint.

    Cite this